Rabeprazole is an antiulcer drug in the class of proton pump inhibitors. It was developed by Eisai Co. and is marketed by Janssen-Cilag as rabeprazole sodium under the brand names AcipHex (pronounced "acifex", referring to pH) in the US, Pariet in Japan and Canada, & Rablet in India.